GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Medpace Holdings Inc (NAS:MEDP) » Definitions » Shiller PE Ratio

Medpace Holdings (Medpace Holdings) Shiller PE Ratio : 104.44 (As of May. 07, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Medpace Holdings Shiller PE Ratio?

As of today (2024-05-07), Medpace Holdings's current share price is $402.10. Medpace Holdings's E10 for the quarter that ended in Mar. 2024 was $3.85. Medpace Holdings's Shiller PE Ratio for today is 104.44.

The historical rank and industry rank for Medpace Holdings's Shiller PE Ratio or its related term are showing as below:

MEDP' s Shiller PE Ratio Range Over the Past 10 Years
Min: 96.62   Med: 102.72   Max: 105.24
Current: 104.44

During the past years, Medpace Holdings's highest Shiller PE Ratio was 105.24. The lowest was 96.62. And the median was 102.72.

MEDP's Shiller PE Ratio is ranked worse than
90.79% of 76 companies
in the Medical Diagnostics & Research industry
Industry Median: 28.215 vs MEDP: 104.44

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Medpace Holdings's adjusted earnings per share data for the three months ended in Mar. 2024 was $3.200. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is $3.85 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Medpace Holdings Shiller PE Ratio Historical Data

The historical data trend for Medpace Holdings's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medpace Holdings Shiller PE Ratio Chart

Medpace Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Medpace Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 104.84

Competitive Comparison of Medpace Holdings's Shiller PE Ratio

For the Diagnostics & Research subindustry, Medpace Holdings's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medpace Holdings's Shiller PE Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Medpace Holdings's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Medpace Holdings's Shiller PE Ratio falls into.



Medpace Holdings Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Medpace Holdings's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=402.10/3.85
=104.44

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medpace Holdings's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Medpace Holdings's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=3.2/129.4194*129.4194
=3.200

Current CPI (Mar. 2024) = 129.4194.

Medpace Holdings Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201312 0.000 98.326 0.000
201403 -0.031 99.695 -0.040
201412 0.000 99.070 0.000
201503 -0.001 99.621 -0.001
201506 0.002 100.684 0.003
201509 -0.003 100.392 -0.004
201512 -0.216 99.792 -0.280
201603 0.087 100.470 0.112
201606 0.125 101.688 0.159
201609 0.130 101.861 0.165
201612 -0.001 101.863 -0.001
201703 0.200 102.862 0.252
201706 0.230 103.349 0.288
201709 0.250 104.136 0.311
201712 0.300 104.011 0.373
201803 0.400 105.290 0.492
201806 0.450 106.317 0.548
201809 0.520 106.507 0.632
201812 0.610 105.998 0.745
201903 0.510 107.251 0.615
201906 0.730 108.070 0.874
201909 0.630 108.329 0.753
201912 0.780 108.420 0.931
202003 0.760 108.902 0.903
202006 0.640 108.767 0.762
202009 1.090 109.815 1.285
202012 1.350 109.897 1.590
202103 1.140 111.754 1.320
202106 1.060 114.631 1.197
202109 1.290 115.734 1.443
202112 1.320 117.630 1.452
202203 1.690 121.301 1.803
202206 1.460 125.017 1.511
202209 2.050 125.227 2.119
202212 2.120 125.222 2.191
202303 2.270 127.348 2.307
202306 1.930 128.729 1.940
202309 2.220 129.860 2.212
202312 2.460 129.419 2.460
202403 3.200 129.419 3.200

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Medpace Holdings  (NAS:MEDP) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Medpace Holdings Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Medpace Holdings's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Medpace Holdings (Medpace Holdings) Business Description

Traded in Other Exchanges
Address
5375 Medpace Way, Cincinnati, OH, USA, 45227
Medpace is a late-stage contract research organization, or CRO, that provides full-service drug development and clinical trial services to small and midsized biotechnology, pharmaceutical, and medical device firms. Medpace also offers ancillary services such as bio-analytical laboratory services and imaging capabilities. The company was founded over 30 years ago, and it has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are principally based in the U.S., but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in February 2014, and it exited Medpace in August 2018.
Executives
Susan E Burwig officer: Exec. VP, Operations C/O MEDPACE HOLDINGS, INC., 5375 MEDPACE WAY, CINCINNATI OH 45227
August J. Troendle director, 10 percent owner, officer: CEO 5375 MEDPACE WAY, CINCINNATI OH 45227
Medpace Investors, Llc 10 percent owner 4620 WESLEY AVENUE, CINCINNATI OH 45212
Robert O. Kraft director ONE CVS DRIVE, WOONSOCKET RI 02895
Kevin M. Brady officer: CFO & Treasurer MEDPACE HOLDINGS, INC., 5375 MEDPACE WAY, CINCINNATI OH 45227
Stephen P Ewald officer: General Counsel & Corp. Secy. C/O MEDPACE HOLDINGS,INC., 5375 MEDPACE WAY, CINTINNATI OH 45227
Femida H. Gwadry-sridhar director 5375 MEDPACE WAY, CINCINNATI OH 45227
Ashley M. Keating director 5375 MEDPACE WAY, CINCINNATI OH 45227
Davenport Fred B Jr director
Brian T Carley director C/O MEDPACE HOLDINGS, INC., 5375 MEDPACE WAY, CINCINNATI OH 45227
Mccarthy Cornelius P. Iii director 5375 MEDPACE WAY, CINCINNATI OH 45227
Jesse J Geiger officer: CFO & COO, Lab Operations C/O MEDPACE HOLDINGS, INC., 5375 MEDPACE WAY, CINCINNATI OH 45227
Tom C King director 5375 MEDPACE WAY, CINCINNATI OH 45227
Medpace Limited Partnership 10 percent owner EAST WING, TRAFALGAR COURT, LES BANQUES, ST. PETER PORT, CHANNEL ISLANDS Y7 GY1 3PP
Cinven Capital Management (v) General Partner Ltd 10 percent owner EAST WING, TRAFALGAR COURT, LES BANQUES, ST. PETER PORT Y7 GY1 3PP